Chronic blockade of interleukin‐1 (IL‐1) prevents and attenuates neuropathic pain behavior and spontaneous ectopic neuronal activity following nerve injury
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Neuropathic pain is a chronic pain state resulting from peripheral nerve injury, characterized by hyperalgesia and allodynia. We have reported that mice with genetic impairment of IL‐1 signaling display attenuated neuropathic pain behavior and ectopic neuronal activity. In order to substantiate the role of IL‐1 in neuropathic pain, WT mice were implanted subcutaneously with osmotic micropumps containing either IL‐1ra or vehicle. Two days following the implantation, two models of neuropathic pain were used; partial nerve injury (spinal nerve transection, SNT), or complete nerve cut (spinal neuroma model). Mechanosensitivity was assessed seven consecutive days following SNT, and on day 7 recordings of spontaneous ectopic activity were performed. In the spinal nerve neuroma model, autotomy scores were recorded up to 35 days. Vehicle‐treated mice developed significant allodynia and autotomy, and clear ectopic activity (4.1±1.1% of the axons); whereas IL‐1ra‐treated mice did not display allodynic response, displayed delayed onset of autotomy and markedly reduced severity of autotomy scores, and displayed reduced spontaneous activity (0.8±0.4% of the axons). To test whether IL‐1 is involved in maintenance of mechanical allodynia, a separate group of WT mice was treated with a single injection of either saline or IL‐1ra four days following SNT, after the allodynic response was already manifested. Whereas saline‐treated mice displayed robust allodynia, acute IL‐1ra treatment induced long‐lasting attenuation of the allodynic response. The results support our hypothesis that IL‐1 signaling plays an important role in neuropathic pain and in the ectopic neuronal activity that underling its development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ho Kim, S., & Mo Chung, J. (1992) · Pain · doi:10.1016/0304-3959(92)90041-9 · Cited by 3,069 · cited 2×
“A growing body of evidence indicates that the pro-inflammatory cytokine interleukin-1 (IL-1) is involved in pain sensation (Watkins and Maier, 2002; Wolf et al., 2003; Shavit et al., 2005; Bessler et al., 2006; Guimaraes et al., 2006), as well as in neuropathic pain (Raghavendra et al., 2002; DeLeo…”
Ledeboer, A., Sloane, E. M., Milligan, E. D., Frank, M. G., Mahony, J. H., Maier, S. F., & Watkins, L. R. (2005) · Pain · doi:10.1016/j.pain.2005.02.009 · Cited by 677
The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy
Tanga, F. Y., Nutile-McMenemy, N., & DeLeo, J. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501634102 · Cited by 634 · cited 1×
“L5 spinal nerve transection was demonstrated to induce pain response that requires central neuroimmune activation (Tanga et al., 2005), suggesting that the allodynia evoked in this model relies on central mechanisms.”
Banks, W. A., Ortiz, L., Plotkin, S. R., & Kastin, A. J. (1991) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20576-6 · Cited by 474 · cited 2×
“As proteins of the IL-1 family can cross the BBB either by specific transporters (Banks et al., 1994; Banks et al., 1989; Banks et al., 1991; Maness et al., 1995), or as the result of changes in BBB permeability induced by IL-1b application (Blamire et al., 2000; Didier et al., 2003; Ferrari et…”
Zhuang, Z.-Y., Kawasaki, Y., Tan, P.-H., Wen, Y.-R., Huang, J., & Ji, R.-R. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.11.003 · Cited by 371 · cited 2×
“TLR4 blockers (Hutchinson et al., 2008), fractalkine antagonists (Zhuang et al., 2007), and minocycline (Raghavendra et al., 2003a,b) were all demonstrated to prevent glial activation and reduce neuropathic pain.”
Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia
Deleo, J. A., Tanga, F. Y., & Tawfik, V. L. (2004) · The Neuroscientist · doi:10.1177/1073858403259950 · Cited by 371
Chacur, M., Milligan, E. D., Gazda, L. S., Armstrong, C., Wang, H., Tracey, K. J., Maier, S. F., & Watkins, L. R. (2001) · Pain · doi:10.1016/s0304-3959(01)00354-2 · Cited by 309 · cited 2×
“Specifically, in animal models of neuropathic pain, elevated levels of pro-inflammatory cytokines were observed at the site of tissue damage, in the central nervous system (CNS) and the relevant dorsal root ganglion (DRG), concomitantly with the development of thermal hyperalgesia and mechanical allodynia (Chacur et a…”
Safety of extended treatment with anakinra in patients with rheumatoid arthritis
Fleischmann, R. M., Tesser, J., Schiff, M. H., Schechtman, J., Burmester, G.-R., Bennett, R., Modafferi, D., Zhou, L., Bell, D., & Appleton, B. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.048371 · Cited by 305
Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
Abramson, S. B. (2002) · Rheumatology · doi:10.1093/rheumatology/41.9.972 · Cited by 217 · cited 2×
“, Thousand Oaks, CA), is already in use for several years as an effective drug therapy for rheumatoid arthritis (Bresnihan and Cunnane, 1998; Abramson and Amin, 2002; Dayer, 2003), without any major side effects (Nuki et al.”
Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin
Maier, S. F., Wiertelak, E. P., Martin, D., & Watkins, L. R. (1993) · Brain Research · doi:10.1016/0006-8993(93)91446-y · Cited by 210 · cited 2×
“The present findings are in accordance with previous studies, demonstrating that the blockade of IL-1 signaling by IL-1ra prevents and even reverses allodynia and hyperalgesia in several inflammation models, including administration of endotoxin (Maier et al., 1993), complete Freund’s adjuvant (Safieh-Garabedian et al.”
Cited by
Inflammasomes in carcinogenesis and anticancer immune responses
Zitvogel, L., Kepp, O., Galluzzi, L., & Kroemer, G. (2012) · Nature Immunology · doi:10.1038/ni.2224 · Cited by 593
Inflammation in the pathophysiology of neuropathic pain
Sommer, C., Leinders, M., & Üçeyler, N. (2018) · Pain · doi:10.1097/j.pain.0000000000001122 · Cited by 493
Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme
Afonina, I. S., Müller, C., Martin, S. J., & Beyaert, R. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.003 · Cited by 490
Neuropathic pain and cytokines: current perspectives
Malcangio, M., Clark, A. K., & Old, E. A. (2013) · Journal of Pain Research · doi:10.2147/jpr.s53660 · Cited by 337
Schwann cell interactions with axons and microvessels in diabetic neuropathy
Gonçalves, N. P., Vægter, C. B., Andersen, H., Østergaard, L., Calcutt, N. A., & Jensen, T. S. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.201 · Cited by 305
Metadata
- Authors
- Gabayl, E., Wolfl, G., Shavitl, Y., Yirmiyal, R., & Tall, M.
- Venue
- European Journal of Pain
- Publisher
- Wiley
- Published
- 2011-03
- Volume
- 15
- Issue
- 3
- Pages
- 242-248
- ISSN
- 1090-3801 (ISSN-L)
- 1532-2149
- OpenAlex
- W2157546454
- Cited by
- 88
- References
- 11
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chronic blockade of interleukin‐1 (IL‐1) prevents and attenuates neuropathic pain behavior and spontaneous ectopic neuronal activity following nerve injury. https://app.cochat.ai/papers/10.1016/j.ejpain.2010.07.012
- The paper
- Gabayl, E., Wolfl, G., Shavitl, Y., Yirmiyal, R., & Tall, M. (2011). Chronic blockade of interleukin‐1 (IL‐1) prevents and attenuates neuropathic pain behavior and spontaneous ectopic neuronal activity following nerve injury. European Journal of Pain. https://doi.org/10.1016/j.ejpain.2010.07.012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.